Menu
New Jersey Immunization Network
Our Mission Statement

The mission of the New Jersey Immunization Network is to protect the health of all individuals through timely, age-appropriate immunization against vaccine-preventable diseases by educating the public, healthcare professionals, and policymakers about vaccine safety and benefits.

  • About NJIN
    • Meeting Schedule
    • Leadership & Staff
    • Committees
    • Join NJIN
  • Infant and Child
  • Adolescents
    • HPV Roundtable
  • Adults
  • Education
    • HPV Roundtable
  • Resources
    • HPV Roundtable
  • Membership
  • Contact Us
Close Menu
26980464-8202675-image-a-9_1586396537603
April 9 2020

Potential breakthrough in search for a coronavirus vaccine as an Australian treatment is tested on COVID-19 for the first time

immunizenjadmin Diseases and Vaccines, Featured

Australia could be one step closer to a coronavirus vaccine breakthrough.

A new vaccine developed by University of Queensland researchers will soon be tested on the live virus for the first time in a biosecurity facility in the Netherlands.

The School of Chemistry and Molecular Biosciences team has joined forces with Dutch company Viroclinics Xplore to conduct pre-clinical studies to get a better understanding of how the vaccine performs before it’s tested on humans.

It comes as testing of another potential coronavirus vaccine began at the CSIRO lab in regional Victoria last week.

As a service organisation, we have committed to realigning our resources, equipment and materials to initiatives to test promising vaccines, anti-virals and immune modulators in the battle against COVID-19 and we have developed a number of preclinical models of COVID-19 infection,’ Viroclinics spokesperson Dr Koert Stittelaar said.

University researchers used rapid response technology from the Epidemic Preparedness Innovations to develop a vaccine, which took three weeks to produce.

The vaccine was developed usinng molecular clamp technology that locks the ‘spike’ protein into a shape which allows the immune system to be able to recognise and then neutralise the virus.

The researchers announced earlier this year it hopes to develop the vaccine within six months through its recently invented rapid response technology. Read More.

Abbott Launches 5-Minute Virus Test for Use Almost Anywhere Don’t skip vaccinations: 8 things pediatricians want parents to know during the coronavirus pandemic

Related Posts

pcp

Featured

PCPs Continue to Struggle

vaccines

Anti Vaxx, Featured

US Government Slow to Act as Anti-Vaxxers Spread Lies on Social Media About Coronavirus Vaccine

Anti-Vaxx COVID

Anti Vaxx, Featured

Youtube gives Del Bigtree the boot about 4 years too late

Recent Posts

  • PCPs Continue to Struggle
  • US Government Slow to Act as Anti-Vaxxers Spread Lies on Social Media About Coronavirus Vaccine
  • Youtube gives Del Bigtree the boot about 4 years too late
  • Kids Plus AAV Toolkit – Shots Heard Round The World
  • No Association Between Influenza Vaccine Exposure in Utero and Adverse Childhood Health Outcomes

Categories

  • Adolescent Immunization
  • Anti Vaxx
  • Are Vaccines Safe?
  • Diseases and Vaccines
  • Featured
  • For Clinicians
  • For Patients
  • News and Highlights (Adolescents)
  • News and Highlights (Adult Immunization)
  • News and Highlights (Infant and Child)
  • Recommended Adult Vaccines
  • Resources
  • Resources – Adult
  • Webinar
  • Why Immunize?
Back To Top
New Jersey Immunization Network
© 2020 New Jersey Immunization Coaltion
Site by Double Dog Communications

New Jersey Immunization Network
50 Millstone Road
Building 200, Suite 130
East Windsor, New Jersey 08520

Phone: 609-842-0014
Fax: 609-842-0015

Connect With Us

  • Join NJIN
  • Twitter
  • Facebook
  • Email